Cargando…

Development and validation of nomograms predicting postoperative survival in patients with chromophobe renal cell carcinoma

OBJECTIVE: The purpose of our study is to construct and validate nomograms that effectively predict postoperative overall survival and cancer-specific survival for patients with chromophobe renal cell carcinoma (chRCC). METHOD: Clinical, social, and pathological data from 6016 patients with chRCC co...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Shuaishuai, Zhu, Jiawei, He, Zhenwei, Ashok, Raj, Xue, Ning, Liu, Zijie, Ding, Li, Zhu, Haitao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9701834/
https://www.ncbi.nlm.nih.gov/pubmed/36452499
http://dx.doi.org/10.3389/fonc.2022.982833
_version_ 1784839627551539200
author Li, Shuaishuai
Zhu, Jiawei
He, Zhenwei
Ashok, Raj
Xue, Ning
Liu, Zijie
Ding, Li
Zhu, Haitao
author_facet Li, Shuaishuai
Zhu, Jiawei
He, Zhenwei
Ashok, Raj
Xue, Ning
Liu, Zijie
Ding, Li
Zhu, Haitao
author_sort Li, Shuaishuai
collection PubMed
description OBJECTIVE: The purpose of our study is to construct and validate nomograms that effectively predict postoperative overall survival and cancer-specific survival for patients with chromophobe renal cell carcinoma (chRCC). METHOD: Clinical, social, and pathological data from 6016 patients with chRCC collected from the SEER database were screened from 2004 to 2015. They were randomly assigned to a training cohort (n = 4212) and a validation cohort (n = 1804) at a 7:3 ratio. Cox regression and least absolute shrinkage and selection operator (LASSO) analyses were used to identify the prognostic factors affecting overall survival (OS) and cancer-specific survival (CSS) and establish nomograms. Their performance was validated internally and externally by calculating Harrell’s C-indexes, area under the curve (AUC), calibration, and decision curves. For external validation, samples from postoperative patients with chRCC at 3 independent centers in Xuzhou, China, were collected. Risk stratification models were built according to the total scores of each patient. Kaplan-Meier curves were generated for the low-risk, intermediate-risk, and high-risk groups to evaluate survival. RESULTS: The C-indexes, AUC curves, and decision curves revealed the high ability of the nomograms in predicting OS and CSS, overall better than that of AJCC and TNM staging. Moreover, in internal and external validation, the calibration curves of 5-, 8-, and 10-year OS agreed with the actual survival. Kaplan-Meier curves indicated significant differences in survival rates among the 3 risk groups in OS or CSS. CONCLUSION: The nomograms showed favourable predictive power for OS and CSS. Thus, they should contribute to evaluating the prognosis of patients with chRCC. Furthermore, the risk stratification models established on the nomograms can guide the prognosis of patients and further treatment.
format Online
Article
Text
id pubmed-9701834
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-97018342022-11-29 Development and validation of nomograms predicting postoperative survival in patients with chromophobe renal cell carcinoma Li, Shuaishuai Zhu, Jiawei He, Zhenwei Ashok, Raj Xue, Ning Liu, Zijie Ding, Li Zhu, Haitao Front Oncol Oncology OBJECTIVE: The purpose of our study is to construct and validate nomograms that effectively predict postoperative overall survival and cancer-specific survival for patients with chromophobe renal cell carcinoma (chRCC). METHOD: Clinical, social, and pathological data from 6016 patients with chRCC collected from the SEER database were screened from 2004 to 2015. They were randomly assigned to a training cohort (n = 4212) and a validation cohort (n = 1804) at a 7:3 ratio. Cox regression and least absolute shrinkage and selection operator (LASSO) analyses were used to identify the prognostic factors affecting overall survival (OS) and cancer-specific survival (CSS) and establish nomograms. Their performance was validated internally and externally by calculating Harrell’s C-indexes, area under the curve (AUC), calibration, and decision curves. For external validation, samples from postoperative patients with chRCC at 3 independent centers in Xuzhou, China, were collected. Risk stratification models were built according to the total scores of each patient. Kaplan-Meier curves were generated for the low-risk, intermediate-risk, and high-risk groups to evaluate survival. RESULTS: The C-indexes, AUC curves, and decision curves revealed the high ability of the nomograms in predicting OS and CSS, overall better than that of AJCC and TNM staging. Moreover, in internal and external validation, the calibration curves of 5-, 8-, and 10-year OS agreed with the actual survival. Kaplan-Meier curves indicated significant differences in survival rates among the 3 risk groups in OS or CSS. CONCLUSION: The nomograms showed favourable predictive power for OS and CSS. Thus, they should contribute to evaluating the prognosis of patients with chRCC. Furthermore, the risk stratification models established on the nomograms can guide the prognosis of patients and further treatment. Frontiers Media S.A. 2022-11-14 /pmc/articles/PMC9701834/ /pubmed/36452499 http://dx.doi.org/10.3389/fonc.2022.982833 Text en Copyright © 2022 Li, Zhu, He, Ashok, Xue, Liu, Ding and Zhu https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Oncology
Li, Shuaishuai
Zhu, Jiawei
He, Zhenwei
Ashok, Raj
Xue, Ning
Liu, Zijie
Ding, Li
Zhu, Haitao
Development and validation of nomograms predicting postoperative survival in patients with chromophobe renal cell carcinoma
title Development and validation of nomograms predicting postoperative survival in patients with chromophobe renal cell carcinoma
title_full Development and validation of nomograms predicting postoperative survival in patients with chromophobe renal cell carcinoma
title_fullStr Development and validation of nomograms predicting postoperative survival in patients with chromophobe renal cell carcinoma
title_full_unstemmed Development and validation of nomograms predicting postoperative survival in patients with chromophobe renal cell carcinoma
title_short Development and validation of nomograms predicting postoperative survival in patients with chromophobe renal cell carcinoma
title_sort development and validation of nomograms predicting postoperative survival in patients with chromophobe renal cell carcinoma
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9701834/
https://www.ncbi.nlm.nih.gov/pubmed/36452499
http://dx.doi.org/10.3389/fonc.2022.982833
work_keys_str_mv AT lishuaishuai developmentandvalidationofnomogramspredictingpostoperativesurvivalinpatientswithchromophoberenalcellcarcinoma
AT zhujiawei developmentandvalidationofnomogramspredictingpostoperativesurvivalinpatientswithchromophoberenalcellcarcinoma
AT hezhenwei developmentandvalidationofnomogramspredictingpostoperativesurvivalinpatientswithchromophoberenalcellcarcinoma
AT ashokraj developmentandvalidationofnomogramspredictingpostoperativesurvivalinpatientswithchromophoberenalcellcarcinoma
AT xuening developmentandvalidationofnomogramspredictingpostoperativesurvivalinpatientswithchromophoberenalcellcarcinoma
AT liuzijie developmentandvalidationofnomogramspredictingpostoperativesurvivalinpatientswithchromophoberenalcellcarcinoma
AT dingli developmentandvalidationofnomogramspredictingpostoperativesurvivalinpatientswithchromophoberenalcellcarcinoma
AT zhuhaitao developmentandvalidationofnomogramspredictingpostoperativesurvivalinpatientswithchromophoberenalcellcarcinoma